|
Cholesterol Headlines
Molecular Mechanism Underlying Severe Anomalies Of The Forebrain Revealed By Researchers
Researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch have now identified and described a molecular mechanism underlying the most common malformation of the brain in humans. In holoprosencephaly (HPE), the forebrain (prosencephalon) is only incompletely formed. Here a binding site (receptor) for cholesterol plays a key role...
Thu, 16 Feb 2012 00:00:00 PST - Source:MedNewsToday
Following Heart Attack, Low Levels Of Lipid Antibodies Increase Complications
Coronary patients with low levels of an immune system antibody called anti-PC, which neutralises parts of the 'bad' cholesterol, run a greater risk of suffering complications following an acute cardiac episode and thus of premature death. This according to new research from Karolinska Institutet published in the scientific periodical The International Journal of Cardiology...
Wed, 08 Feb 2012 00:00:00 PST - Source:MedNewsToday
Cholesterol-Lowering Drugs From Website Advertising Risky For Purchasers
A new study published in the journal Pharmacoepidemiology & Drug Safety reveals that internet sites selling prescription statins directly to consumers are widespread, and that most websites advertising statins for sale to the general public contain very poor levels of information relevant to safe use of the medicine and side effects...
Sun, 05 Feb 2012 00:00:00 PST - Source:MedNewsToday
Statins Work As Well On Females As Males
Statins given to female patients are as effective in preventing the occurrence of cardiovascular events as they are for men, researchers from Boston and New York reported in the Journal of the American College of Cardiology. Cardiovascular events include stroke, heart attack, and angina. William J. Kostis, Ph.D., M.D...
Tue, 31 Jan 2012 12:00:00 PST - Source:MedNewsToday
Study Of Genetic Regulation Of Metabolomic Biomarkers - Paths To Cardiovascular Diseases And Type 2 Diabetes
In a study into the genetic variance of human metabolism, researchers have identified thirty one regions of the genome that were associated with levels of circulating metabolites, i.e., small molecules that take part in various chemical reactions of human body...
Mon, 30 Jan 2012 01:00:00 PST - Source:MedNewsToday
Identification Of Entry Point For Hepatitis C Infection
A molecule embedded in the membrane of human liver cells that aids in cholesterol absorption also allows the entry of hepatitis C virus, the first step in hepatitis C infection, according to research at the University of Illinois at Chicago College of Medicine...
Thu, 26 Jan 2012 00:00:00 PST - Source:MedNewsToday
Statins May Work Against Certain Breast Cancers
Statins are commonly prescribed to lower cholesterol, but a recent study suggest certain types of breast cancer may respond to treatment with statins...
Mon, 23 Jan 2012 02:00:00 PST - Source:MedNewsToday
A Biomarker Test For Atherosclerosis To Seek Out The Silent Killer
Furring of the arteries, atherosclerosis, is a leading cause of death across the world. Atherosclerosis leads to peripheral arterial disease, coronary heart disease, stroke and heart attacks. However, atherosclerosis is a sneaky killer - most people do not realize they have it until they have cardiovascular disease (CV)...
Sat, 14 Jan 2012 00:00:00 PST - Source:MedNewsToday
Novel Target In Artery Plaque Discovered As Potential Therapeutic Intervention
A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries. The research, published online by Nature Immunology on January 8, 2012, explains why cholesterol-laden, coronary artery disease-causing cells called macrophages, accumulate in artery plaques...
Tue, 10 Jan 2012 03:00:00 PST - Source:MedNewsToday
Benefits Of Statin Therapy May Extend Beyond Lowering Lipids
People with high cholesterol are at risk of heart attack and stroke because atherosclerotic plaques within their arteries can rupture triggering the formation of a blood clot called an occlusive thrombus that cuts off the blood supply to their heart or brain. For years, scientists have studied the cause of this abnormal clotting...
Fri, 06 Jan 2012 00:00:00 PST - Source:MedNewsToday
As Part Of A Heart-Healthy Diet, Eating Lean Beef Daily Can Help Lower Cholesterol
A new study published in the January 2012 edition of American Journal of Clinical Nutrition shows that beef can play a role in a cholesterol-lowering diet, despite commonly held beliefs. The study found that diets including lean beef every day are as effective in lowering total and LDL "bad" cholesterol as the "gold standard" of heart-healthy diets (DASH, Dietary Approaches to Stop Hypertension)...
Wed, 28 Dec 2011 00:00:00 PST - Source:MedNewsToday
Cholesterol-Lowering Drugs May Reduce Mortality For Influenza Patients
Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study released online by The Journal of Infectious Diseases...
Sat, 17 Dec 2011 02:00:00 PST - Source:MedNewsToday
Cholesterol-Lowering Medication Accelerates Depletion Of Plaque In Arteries
In a new study, NYU Langone Medical Center researchers have discovered how cholesterol-lowering drugs called statins promote the breakdown of plaque in the arteries. The study was published online by the journal PLoS One on December 6, 2011...
Wed, 14 Dec 2011 02:00:00 PST - Source:MedNewsToday
Agent Responsible For Protection Against Early Stages Of Atherosclerosis Identified
Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol. The findings, which appear on-line in Circulation, may have significant public health implications...
Wed, 14 Dec 2011 01:00:00 PST - Source:MedNewsToday
Low-Density Lipoprotein Treatment Breakthrough
A novel breakthrough advance in fighting low-density lipoprotein (LDL) or "bad" cholesterol in the body has been announced by investigators from the University of Leicester and University of California Los Angeles (UCLA). The universities have filed two patents in order to develop targeted medications designed to lower levels of LDL...
Mon, 12 Dec 2011 09:00:00 PST - Source:MedNewsToday
New Advance Announced In Reducing 'Bad' Cholesterol
Scientists from the University of Leicester and the University of California Los Angeles (UCLA) have announced a major advance towards developing drugs to tackle dangerous, or 'bad', cholesterol in the body. They have filed two patents for developing targeted drugs that would act as a catalyst for lowering levels of 'bad' cholesterol...
Sat, 10 Dec 2011 00:00:00 PST - Source:MedNewsToday
Potential Breast Cancer Prevention Agent Found To Lower Levels Of 'Good' Cholesterol Over Time
Exemestane steadily lowered levels of "good" cholesterol in women taking the agent as part of a breast cancer prevention study, say researchers at Georgetown Lombardi Comprehensive Cancer Center. Exemestane, an aromatase inhibitor used to treat estrogen receptor-positive breast cancer, is being tested to prevent breast cancer in women at an increased risk of developing the disease...
Sat, 10 Dec 2011 00:00:00 PST - Source:MedNewsToday
New Advance Announced In Reducing 'bad' Cholesterol
Scientists from the University of Leicester and the University of California Los Angeles (UCLA) have announced a major advance towards developing drugs to tackle dangerous, or 'bad', cholesterol in the body. They have filed two patents for developing targeted drugs that would act as a catalyst for lowering levels of 'bad' cholesterol...
Sat, 10 Dec 2011 00:00:00 PST - Source:MedNewsToday
New Advance Announced In Reducing 'bad' Cholesterol
Scientists from the University of Leicester and the University of California Los Angeles (UCLA) have announced a major advance towards developing drugs to tackle dangerous, or 'bad', cholesterol in the body. They have filed two patents for developing targeted drugs that would act as a catalyst for lowering levels of 'bad' cholesterol...
Fri, 09 Dec 2011 02:00:00 PST - Source:MedNewsToday
Preventing Atherosclerosis
By changing the behavior of certain cells within human blood vessels, Cornell University researchers have discovered important clues as to the underlying causes of atherosclerosis - a discovery researchers hope can lead to more targeted drug therapies for the prevention of the disease...
Fri, 09 Dec 2011 01:00:00 PST - Source:MedNewsToday
Gene Mutation Allows You To Have Your Cream And Eat It, Too
People who carry a malfunctioning copy of a particular gene are especially good at clearing fat from their systems. The report in the December Cell Metabolism, a Cell Press publication, shows how the mutant gene influences metabolism in this way...
Wed, 07 Dec 2011 01:00:00 PST - Source:MedNewsToday
End Of The Road For Pfizer's Lipitor
The FDA approved today a generic version of Pfizer's Lipitor, one of the world's best selling drugs. Known pharmaceutically as atorvastatin calcium tablets, Lipitor is used to reduce cholesterol. The generic version will be manufactured by Ohm Laboratories in New Brunswick, N.J. Cholesterol itself is not a major problem and is, in fact, an essential nutrient for the body...
Thu, 01 Dec 2011 19:00:00 PST - Source:MedNewsToday
Cholesterol-Lowering Lipitor: FDA Okays First Generic Version
The US Food and Drug Administration (FDA) announced on Wednesday that it has approved the first generic version of the world's top-selling medicine, the cholesterol-lowering drug Lipitor (atorvastatin), currently marketed by Pfizer Inc...
Thu, 01 Dec 2011 03:00:00 PST - Source:MedNewsToday
Cholesterol Levels And Heart Disease Biomarkers In Diabetics Improved By Vitamin D-Fortified Yoghurt
People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics...
Sun, 27 Nov 2011 00:00:00 PST - Source:MedNewsToday
Vascular Lipid Accumulation Seen In Young Transparent Zebrafish
A study using genetically modified zebrafish to visualize early events involved in development of human atherosclerosis describes an efficient model - one that the researchers say offers many applications for testing the potential effectiveness of new antioxidant and dietary therapies...
Wed, 23 Nov 2011 00:00:00 PST - Source:MedNewsToday
|
|
|
